MedTrace Logo

Myocardial Infarction With Non-Obstructive Coronary Arteries in the Greek Population

NCT04186676 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-02-01

No results posted yet for this study

Summary

The MINOCA-GR registry will be the first nationwide study aiming to obtain data regarding prevalence, demographics, clinical profile, previous anginal status, presence of cardiovascular risk factors, management and outcomes in patients with Myocardial Infarction with Non-Obstructive Coronary Arteries. An additional purpose of the registry is to highlight, for the first time worldwide to the best of the investigator's knowledge, the role of cardiac computed tomography angiography for risk stratification and personalized therapeutic approach in MINOCA patients.

Conditions

  • Acute Myocardial Infarction
  • Non-Obstructive Coronary Atherosclerosis
  • Ischemic Heart Disease
  • Angina Pectoris
  • Coronary Microvascular Disease

Interventions

OTHER

MINOCA registry

Prevalence, demographics, clinical profile, anginal status, presence of cardiovascular risk factors, management and outcomes

DIAGNOSTIC_TEST

CCTA Phenotypes

1. Complete normal coronary arteries 2. Diffuse non-obstructive coronary artery disease 3. Non-obstructive high-risk plaques 4. Myocardial bridges

Sponsors & Collaborators

  • New York University

    collaborator OTHER

  • University of Zurich

    collaborator OTHER

  • AHEPA University Hospital

    lead OTHER

Principal Investigators

  • Georgios Giannakoulas, MD, PhD · AHEPA University Hospital of Thessaloniki

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2024-01-01
Completion
2024-01-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04186676 on ClinicalTrials.gov